199 related articles for article (PubMed ID: 19479616)
21. Arsenic: a new place?
Vincent PC
Pathology; 1999 May; 31(2):81-2. PubMed ID: 10399159
[No Abstract] [Full Text] [Related]
22. Acute promyelocytic leukemia following mitoxantrone as single agent for the treatment of multiple sclerosis.
Vicari AM; Ciceri F; Folli F; Lanzi R; Colombo B; Comi G; Camba L
Leukemia; 1998 Mar; 12(3):441-2. PubMed ID: 9529141
[No Abstract] [Full Text] [Related]
23. Unusual manifestations of acute leukemia. Case 1. CNS extramedullary relapse of acute promyelocytic leukemia after arsenic trioxide-induced remission.
Au WY; Ma SK; Ooi C; Liang R; Kwong YL
J Clin Oncol; 2000 Oct; 18(19):3435-7. PubMed ID: 11013284
[No Abstract] [Full Text] [Related]
24. Risk of acute promyelocytic leukemia in multiple sclerosis: coding variants of DNA repair genes.
Hasan SK; Buttari F; Ottone T; Voso MT; Hohaus S; Marasco E; Mantovani V; Garagnani P; Sanz MA; Cicconi L; Bernardi G; Centonze D; Lo-Coco F
Neurology; 2011 Mar; 76(12):1059-65. PubMed ID: 21346221
[TBL] [Abstract][Full Text] [Related]
25. Non-lethal bone marrow necrosis under first-line arsenic trioxide therapy in acute promyelocytic leukaemia.
Ianotto JC; Tempescul A; Eveillard JR; Charles F; Berthou C
Acta Haematol; 2010; 123(3):146-7. PubMed ID: 20134156
[No Abstract] [Full Text] [Related]
26. Pseudotumor cerebri after treatment of relapsed acute promyelocytic leukemia with arsenic trioxide.
Galm O; Fabry U; Osieka R
Leukemia; 2000 Feb; 14(2):343-4. PubMed ID: 10673758
[No Abstract] [Full Text] [Related]
27. Arsenic trioxide treatment of relapsed acute promyelocytic leukaemia: initial Australian experience.
Spencer A; Firkin F
Aust N Z J Med; 1999 Jun; 29(3):385-6. PubMed ID: 10868510
[No Abstract] [Full Text] [Related]
28. Presenting features and treatment outcome of acute promyelocytic leukemia arising after multiple sclerosis.
Ammatuna E; Montesinos P; Hasan SK; Ramadan SM; Esteve J; Hubmann M; Pagoni M; Grimwade D; Sanz MA; Lo-Coco F
Haematologica; 2011 Apr; 96(4):621-5. PubMed ID: 21193421
[TBL] [Abstract][Full Text] [Related]
29. [Pharmacological and clinical properties of arsenic trioxide (Trisenox) for relapse or refractory acute promyelocytic leukemia therapy].
Tajima M
Nihon Yakurigaku Zasshi; 2005 Jun; 125(6):389-96. PubMed ID: 16079563
[No Abstract] [Full Text] [Related]
30. [Clinical observation and follow-up study on acute promyelocytic leukemia in childhood treated mainly with arsenic trioxide].
Hao LC; Wang H; Zhang LZ
Zhonghua Er Ke Za Zhi; 2005 Jul; 43(7):534-5. PubMed ID: 16083560
[No Abstract] [Full Text] [Related]
31. Introduction.
Tallman MS
Semin Hematol; 2002 Apr; 39(2 Suppl 1):1-2. PubMed ID: 12012314
[No Abstract] [Full Text] [Related]
32. Arsenic trioxide entered cerebrospinal fluid with the help of mannitol overwhelm the meningeal relapse of acute promyelocytic leukemia.
Jin Z; Ran M; Man Z
Haematologica; 2007 Sep; 92(9):e82-4. PubMed ID: 17768137
[No Abstract] [Full Text] [Related]
33. Guest editorial: acute promyelocytic leukemia: change from "highly fatal to highly curable" leukemia.
Komatsu N
Int J Hematol; 2014 Jul; 100(1):16-7. PubMed ID: 24912657
[No Abstract] [Full Text] [Related]
34. Retinoic acid syndrome induced by arsenic trioxide in treating recurrent all-trans retinoic acid resistant acute promyelocytic leukemia.
Che-Pin Lin ; Huang MJ; Chang IY; Lin WY; Sheu YT
Leuk Lymphoma; 2000 Jun; 38(1-2):195-8. PubMed ID: 10811463
[TBL] [Abstract][Full Text] [Related]
35. Treatment of relapsed acute promyelocytic leukemia by arsenic trioxide in Iran.
Alimoghaddam K; Ghavamzadeh A; Jahani M; Mousavi A; Iravani M; Rostami S; Ghaffari H; Hosseini R; Jalili M
Arch Iran Med; 2011 May; 14(3):167-9. PubMed ID: 21529103
[TBL] [Abstract][Full Text] [Related]
36. Two cases of monocular visual loss during oral arsenic trioxide therapy of acute promyelocytic leukemia.
Au WY; Hon C; Yau K; Lai WW; Fong BM; Tam S; Kwong YL
Am J Hematol; 2009 Oct; 84(10):699. PubMed ID: 19705432
[No Abstract] [Full Text] [Related]
37. Elemental arsenic entered the cerebrospinal fluid during oral arsenic trioxide treatment of meningeal relapse of acute promyelocytic leukemia.
Au WY; Tam S; Fong BM; Kwong YL
Blood; 2006 Apr; 107(7):3012-3. PubMed ID: 16554490
[No Abstract] [Full Text] [Related]
38. [Arsenic trioxide in the treatment of acute promyelocytic leukaemia].
Ercilla Liceaga M; Andueza Granados K; Fernández González I; Barcia Romero MJ
Farm Hosp; 2003; 27(2):93-100. PubMed ID: 12717564
[TBL] [Abstract][Full Text] [Related]
39. Swallowing a bitter pill-oral arsenic trioxide for acute promyelocytic leukemia.
Torka P; Al Ustwani O; Wetzler M; Wang ES; Griffiths EA
Blood Rev; 2016 May; 30(3):201-11. PubMed ID: 26709030
[TBL] [Abstract][Full Text] [Related]
40. Treatment of acute promyelocytic leukemia with arsenic trioxide.
Conrad ME
N Engl J Med; 1999 Apr; 340(13):1043-5. PubMed ID: 10189286
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
